secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cellectar Biosciences, Inc. (CLRB)
CIK:        0001279704
Form:       8-K
Filed at:   2025-06-18T23:59:59+00:00
Accession:  0001104659-25-060661
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cellectar Biosciences announces 1-for-30 reverse stock split; effective June 24, 2025
--------------------------------------------------------------------------------

- Approved by stockholders at June 13, 2025 annual meeting; board set final ratio as 1-for-30.
- Reduces outstanding shares from ~54.4M to ~1.8M; effective at 12:01 a.m. ET on June 24.
- Fractional shareholders will receive cash in lieu; authorized shares and par value unchanged.
- Ticker remains CLRB on Nasdaq; new CUSIP number 15117F880 begins June 24.
- Outstanding options, warrants, and preferred stock conversion ratios adjust proportionately.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1279704/000110465925060661/0001104659-25-060661-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1279704/000110465925060661/tm2518341d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-060661

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer